Cargando…
Polysomnographic Predictors of Treatment Response to Cognitive Behavioral Therapy for Insomnia in Participants With Co-morbid Insomnia and Sleep Apnea: Secondary Analysis of a Randomized Controlled Trial
OBJECTIVE: Co-morbid insomnia and sleep apnea (COMISA) is a common and debilitating condition that is more difficult to treat compared to insomnia or sleep apnea-alone. Emerging evidence suggests that cognitive behavioral therapy for insomnia (CBTi) is effective in patients with COMISA, however, tho...
Autores principales: | Sweetman, Alexander, Lechat, Bastien, Catcheside, Peter G., Smith, Simon, Antic, Nick A., O’Grady, Amanda, Dunn, Nicola, McEvoy, R. Doug, Lack, Leon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129160/ https://www.ncbi.nlm.nih.gov/pubmed/34017296 http://dx.doi.org/10.3389/fpsyg.2021.676763 |
Ejemplares similares
-
P139 Co-morbid insomnia and sleep apnoea (COMISA): Identifying patients that are responsive to continuous positive airway pressure therapy
por: Sweetman, A, et al.
Publicado: (2021) -
P018 Effect of CBT-I on sleep-wake state discrepancy in individuals with co-morbid insomnia and sleep apnoea: A randomised controlled trial
por: Bensen-Boakes, D, et al.
Publicado: (2022) -
Cognitive behavioural therapy for insomnia reduces sleep apnoea severity: a randomised controlled trial
por: Sweetman, Alexander, et al.
Publicado: (2020) -
P073 Co-morbid insomnia and obstructive sleep apnoea is associated with all-cause mortality and cardiovascular event risk
por: Lechat, B, et al.
Publicado: (2021) -
Co-Morbid Insomnia and Sleep Apnea (COMISA): Prevalence, Consequences, Methodological Considerations, and Recent Randomized Controlled Trials
por: Sweetman, Alexander, et al.
Publicado: (2019)